Announced Fri, 3 Jul · 20:27 IST
Vaishali Pharma allots shares to Kesar Pharma via share swap for 26.95% acquisition
Fund Raising View source PDF
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹7.30
prior close
₹7.57
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.6———+1.9-0.8-1.4+3.6+8.6+7.5+6.0———
Up moveDown movePending
AI summary
Vaishali Pharma allotted 45,37,865 equity shares at Rs. 20 each (total Rs. 9.08 crore) to Kesar Pharma Limited (KPL) on a preferential basis as non-cash consideration for acquiring 26.95% stake in KPL through a share swap. Post allotment, KPL holds 3.36% in Vaishali Pharma. Paid-up equity capital increased from Rs. 26.09 crore to Rs. 27 crore across about 13.50 crore shares.
Likely market impact
Share-swap acquisition of 26.95% in KPL causes about 3.5% equity dilution for existing holders; non-cash deal preserves company liquidity.